Elizabeth A. Sellars
Associate Professor
Also affiliated: Cincinnati Children's Hospital Medical Center (2011); National Institutes of Health (2004); Arkansas Children's Hospital (2013–2025); Vanderbilt University (2020); University of Arkansas Medical Center (2014–2015); Eunice Kennedy Shriver National Institute of Child Health and Human Development (2004); Royal Academy of Music (2006–2008); University of Cincinnati Medical Center (2011)
Faculty Researcher
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Elizabeth A. Sellars is an Associate Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences. Her research focuses on the genetic basis of developmental disorders, particularly intellectual disability and neurodevelopmental delays. Sellars has published work investigating deleterious, protein-altering variants in genes such as ZMYM3 and AFF3, which are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy. Her research also extends to rare genetic conditions, including ankyloblepharon-ectodermal defects-cleft lip/palate syndrome linked to novel tumor protein p63 gene variants. Additionally, Sellars has explored the implementation of pharmacogenomics testing in a clinical setting, as evidenced by her experience at Arkansas Children’s Hospital. Her scholarship metrics include an h-index of 18 with over 1,400 citations across 38 publications.
Metrics
- h-index: 18
- Publications: 38
- Citations: 1,438
Selected Publications
-
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome in monozygotic twins with a novel tumor protein p63 gene pathogenic variant (2025)
-
P288: A review of phenotypic and genetic data in craniofacial microsomia cases from a multidisciplinary craniofacial clinic (2025)
-
eP238: Inner epicanthal and nasal pits as presenting feature of holoprosencephaly (2022)
-
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital (2021)
-
Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy (2021)
-
NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism (2020)
-
Clinical spectrum of individuals with pathogenic <i> <b>N</b> F1 </i> missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1 (2019)
-
Cover Image, Volume 176A, Number 4, April 2018 (2018)
-
Biallelic mutations in FDXR cause neurodegeneration associated with inflammation (2018)
-
Genetic Considerations in Infants with Congenital Anomalies (2018)
-
Natural history and genotype‐phenotype correlations in 72 individuals with <i>SATB2</i>‐associated syndrome (2018)
-
Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy (2017)
-
Severe Metabolic Acidosis and Hepatopathy due to Leukoencephalopathy with Thalamus and Brainstem Involvement and High Lactate (2016)
-
Whole exome sequencing reveals <i><scp>EP</scp>300</i> mutation in mildly affected female: expansion of the spectrum (2016)
-
<i>COL1A1</i> and <i>COL1A2</i> sequencing results in cohort of patients undergoing evaluation for potential child abuse (2016)
Grants & Funding
As listed on this researcher's institutional profile.
- Arkansas Reproductive Health Services Monitoring (ARHMS) UAMS ACHRI Flow Through Principal Investigator
Collaboration Network
Top Collaborators
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
- Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy
Similar Researchers
Based on overlapping research topics